Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of dutasteride on the risk of prostate cancer.
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group. Andriole GL, et al. Among authors: brawley ow. N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127. N Engl J Med. 2010. PMID: 20357281 Free article. Clinical Trial.
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.
Andriole GL, Bostwick D, Brawley OW, Gomella L, Marberger M, Montorsi F, Pettaway C, Tammela TL, Teloken C, Tindall D, Freedland SJ, Somerville MC, Wilson TH, Fowler I, Castro R, Rittmaster RS; REDUCE Study Group. Andriole GL, et al. Among authors: brawley ow. J Urol. 2011 Jan;185(1):126-31. doi: 10.1016/j.juro.2010.09.011. Epub 2010 Nov 12. J Urol. 2011. PMID: 21074214 Clinical Trial.
Prevention and early detection of prostate cancer.
Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, Eeles RA, Ford LG, Hamdy FC, Holmberg L, Ilic D, Key TJ, La Vecchia C, Lilja H, Marberger M, Meyskens FL, Minasian LM, Parker C, Parnes HL, Perner S, Rittenhouse H, Schalken J, Schmid HP, Schmitz-Dräger BJ, Schröder FH, Stenzl A, Tombal B, Wilt TJ, Wolk A. Cuzick J, et al. Among authors: brawley ow. Lancet Oncol. 2014 Oct;15(11):e484-92. doi: 10.1016/S1470-2045(14)70211-6. Lancet Oncol. 2014. PMID: 25281467 Free PMC article. Review.
Design of the Prostate Cancer Prevention Trial (PCPT).
Feigl P, Blumenstein B, Thompson I, Crowley J, Wolf M, Kramer BS, Coltman CA Jr, Brawley OW, Ford LG. Feigl P, et al. Among authors: brawley ow. Control Clin Trials. 1995 Jun;16(3):150-63. doi: 10.1016/0197-2456(94)00xxx-m. Control Clin Trials. 1995. PMID: 7540965 Clinical Trial.
Chemoprevention of prostate cancer.
Brawley OW, Thompson IM. Brawley OW, et al. Urology. 1994 May;43(5):594-9. doi: 10.1016/0090-4295(94)90169-4. Urology. 1994. PMID: 8165761 Review.
Trends in prostate cancer in the United States.
Brawley OW. Brawley OW. J Natl Cancer Inst Monogr. 2012 Dec;2012(45):152-6. doi: 10.1093/jncimonographs/lgs035. J Natl Cancer Inst Monogr. 2012. PMID: 23271766 Free PMC article.
Prostate cancer prevention trials in the USA.
Brawley OW, Parnes H. Brawley OW, et al. Eur J Cancer. 2000 Jun;36(10):1312-5. doi: 10.1016/s0959-8049(00)00105-2. Eur J Cancer. 2000. PMID: 10882873 Review.
The future of prostate cancer prevention.
Brawley OW, Barnes S, Parnes H. Brawley OW, et al. Ann N Y Acad Sci. 2001 Dec;952:145-52. doi: 10.1111/j.1749-6632.2001.tb02735.x. Ann N Y Acad Sci. 2001. PMID: 11795434 Review.
Phase III prostate cancer chemoprevention trials.
Parnes HL, Brawley OW, Minasian LM, Ford LG. Parnes HL, et al. Among authors: brawley ow. Recent Results Cancer Res. 2014;202:73-7. doi: 10.1007/978-3-642-45195-9_9. Recent Results Cancer Res. 2014. PMID: 24531780
234 results